BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35627278)

  • 1. New Insights into the Neuromyogenic Spectrum of a Gain of Function Mutation in SPTLC1.
    Kölbel H; Kraft F; Hentschel A; Czech A; Gangfuss A; Mohassel P; Nguyen C; Stenzel W; Schara-Schmidt U; Preuße C; Roos A
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627278
    [No Abstract]   [Full Text] [Related]  

  • 2. SPTLC1 p.Leu38Arg, a novel mutation associated with childhood ALS.
    Lone MA; Zeng S; Bourquin F; Wang M; Huang S; Lin Z; Tang B; Zhang R; Hornemann T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159359. PubMed ID: 37348646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins.
    Lone MA; Aaltonen MJ; Zidell A; Pedro HF; Morales Saute JA; Mathew S; Mohassel P; Bönnemann CG; Shoubridge EA; Hornemann T
    J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35900868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis.
    Mohassel P; Donkervoort S; Lone MA; Nalls M; Gable K; Gupta SD; Foley AR; Hu Y; Saute JAM; Moreira AL; Kok F; Introna A; Logroscino G; Grunseich C; Nickolls AR; Pourshafie N; Neuhaus SB; Saade D; Gangfuß A; Kölbel H; Piccus Z; Le Pichon CE; Fiorillo C; Ly CV; Töpf A; Brady L; Specht S; Zidell A; Pedro H; Mittelmann E; Thomas FP; Chao KR; Konersman CG; Cho MT; Brandt T; Straub V; Connolly AM; Schara U; Roos A; Tarnopolsky M; Höke A; Brown RH; Lee CH; Hornemann T; Dunn TM; Bönnemann CG
    Nat Med; 2021 Jul; 27(7):1197-1204. PubMed ID: 34059824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent de novo
    Syeda SB; Lone MA; Mohassel P; Donkervoort S; Munot P; França MC; Galarza-Brito JE; Eckenweiler M; Asamoah A; Gable K; Majumdar A; Schumann A; Gupta SD; Lakhotia A; Shieh PB; Foley AR; Jackson KE; Chao KR; Winder TL; Catapano F; Feng L; Kirschner J; Muntoni F; Dunn TM; Hornemann T; Bönnemann CG
    J Neurol Neurosurg Psychiatry; 2024 Jan; 95(2):103-113. PubMed ID: 38041679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent
    Dohrn MF; Beijer D; Lone MA; Bayraktar E; Oflazer P; Orbach R; Donkervoort S; Foley AR; Rose A; Lyons M; Louie RJ; Gable K; Dunn T; Chen S; Danzi MC; Synofzik M; Bönnemann CG; Nazlı Başak A; Hornemann T; Zuchner S
    J Neurol Neurosurg Psychiatry; 2024 Feb; 95(3):201-205. PubMed ID: 38041684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation screening of SPTLC1 and SPTLC2 in amyotrophic lateral sclerosis.
    Li C; Hou Y; Wei Q; Lin J; Jiang Z; Jiang Q; Yang T; Xiao Y; Huang J; Cheng Y; Ou R; Liu K; Chen X; Song W; Zhao B; Wu Y; Cao B; Chen Y; Shang H
    Hum Genomics; 2023 Mar; 17(1):28. PubMed ID: 36966328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A de novo c.113 T > C: p.L38R mutation of
    Liu X; He J; Yu W; Fan D
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Nov; 23(7-8):634-637. PubMed ID: 36204986
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis.
    Johnson JO; Chia R; Miller DE; Li R; Kumaran R; Abramzon Y; Alahmady N; Renton AE; Topp SD; Gibbs JR; Cookson MR; Sabir MS; Dalgard CL; Troakes C; Jones AR; Shatunov A; Iacoangeli A; Al Khleifat A; Ticozzi N; Silani V; Gellera C; Blair IP; Dobson-Stone C; Kwok JB; Bonkowski ES; Palvadeau R; Tienari PJ; Morrison KE; Shaw PJ; Al-Chalabi A; Brown RH; Calvo A; Mora G; Al-Saif H; Gotkine M; Leigh F; Chang IJ; Perlman SJ; Glass I; Scott AI; Shaw CE; Basak AN; Landers JE; Chiò A; Crawford TO; Smith BN; Traynor BJ; ; Smith BN; Ticozzi N; Fallini C; Gkazi AS; Topp SD; Scotter EL; Kenna KP; Keagle P; Tiloca C; Vance C; Troakes C; Colombrita C; King A; Pensato V; Castellotti B; Baas F; Ten Asbroek ALMA; McKenna-Yasek D; McLaughlin RL; Polak M; Asress S; Esteban-Pérez J; Stevic Z; D'Alfonso S; Mazzini L; Comi GP; Del Bo R; Ceroni M; Gagliardi S; Querin G; Bertolin C; van Rheenen W; Rademakers R; van Blitterswijk M; Lauria G; Duga S; Corti S; Cereda C; Corrado L; Sorarù G; Williams KL; Nicholson GA; Blair IP; Leblond-Manry C; Rouleau GA; Hardiman O; Morrison KE; Veldink JH; van den Berg LH; Al-Chalabi A; Pall H; Shaw PJ; Turner MR; Talbot K; Taroni F; García-Redondo A; Wu Z; Glass JD; Gellera C; Ratti A; Brown RH; Silani V; Shaw CE; Landers JE; Dalgard CL; Adeleye A; Soltis AR; Alba C; Viollet C; Bacikova D; Hupalo DN; Sukumar G; Pollard HB; Wilkerson MD; Martinez EM; Abramzon Y; Ahmed S; Arepalli S; Baloh RH; Bowser R; Brady CB; Brice A; Broach J; Campbell RH; Camu W; Chia R; Cooper-Knock J; Ding J; Drepper C; Drory VE; Dunckley TL; Eicher JD; England BK; Faghri F; Feldman E; Floeter MK; Fratta P; Geiger JT; Gerhard G; Gibbs JR; Gibson SB; Glass JD; Hardy J; Harms MB; Heiman-Patterson TD; Hernandez DG; Jansson L; Kirby J; Kowall NW; Laaksovirta H; Landeck N; Landi F; Le Ber I; Lumbroso S; MacGowan DJL; Maragakis NJ; Mora G; Mouzat K; Murphy NA; Myllykangas L; Nalls MA; Orrell RW; Ostrow LW; Pamphlett R; Pickering-Brown S; Pioro EP; Pletnikova O; Pliner HA; Pulst SM; Ravits JM; Renton AE; Rivera A; Robberecht W; Rogaeva E; Rollinson S; Rothstein JD; Scholz SW; Sendtner M; Shaw PJ; Sidle KC; Simmons Z; Singleton AB; Smith N; Stone DJ; Tienari PJ; Troncoso JC; Valori M; Van Damme P; Van Deerlin VM; Van Den Bosch L; Zinman L; Landers JE; Chiò A; Traynor BJ; Angelocola SM; Ausiello FP; Barberis M; Bartolomei I; Battistini S; Bersano E; Bisogni G; Borghero G; Brunetti M; Cabona C; Calvo A; Canale F; Canosa A; Cantisani TA; Capasso M; Caponnetto C; Cardinali P; Carrera P; Casale F; Chiò A; Colletti T; Conforti FL; Conte A; Conti E; Corbo M; Cuccu S; Dalla Bella E; D'Errico E; DeMarco G; Dubbioso R; Ferrarese C; Ferraro PM; Filippi M; Fini N; Floris G; Fuda G; Gallone S; Gianferrari G; Giannini F; Grassano M; Greco L; Iazzolino B; Introna A; La Bella V; Lattante S; Lauria G; Liguori R; Logroscino G; Logullo FO; Lunetta C; Mandich P; Mandrioli J; Manera U; Manganelli F; Marangi G; Marinou K; Marrosu MG; Martinelli I; Messina S; Moglia C; Mora G; Mosca L; Murru MR; Origone P; Passaniti C; Petrelli C; Petrucci A; Pozzi S; Pugliatti M; Quattrini A; Ricci C; Riolo G; Riva N; Russo M; Sabatelli M; Salamone P; Salivetto M; Salvi F; Santarelli M; Sbaiz L; Sideri R; Simone I; Simonini C; Spataro R; Tanel R; Tedeschi G; Ticca A; Torriello A; Tranquilli S; Tremolizzo L; Trojsi F; Vasta R; Vacchiano V; Vita G; Volanti P; Zollino M; Zucchi E
    JAMA Neurol; 2021 Oct; 78(10):1236-1248. PubMed ID: 34459874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment.
    Fiorillo C; Capodivento G; Geroldi A; Tozza S; Moroni I; Mohassel P; Cataldi M; Campana C; Morando S; Panicucci C; Pedemonte M; Brolatti N; Siliquini S; Traverso M; Baratto S; Debellis D; Magri S; Prada V; Bellone E; Salpietro V; Donkervoort S; Gable K; Gupta SD; Dunn TM; Bönnemann CG; Taroni F; Bruno C; Schenone A; Mandich P; Nobbio L; Nolano M
    Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12842. PubMed ID: 35904184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I.
    Rotthier A; Penno A; Rautenstrauss B; Auer-Grumbach M; Stettner GM; Asselbergh B; Van Hoof K; Sticht H; Lévy N; Timmerman V; Hornemann T; Janssens K
    Hum Mutat; 2011 Jun; 32(6):E2211-25. PubMed ID: 21618344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship.
    Bode H; Bourquin F; Suriyanarayanan S; Wei Y; Alecu I; Othman A; Von Eckardstein A; Hornemann T
    Hum Mol Genet; 2016 Mar; 25(5):853-65. PubMed ID: 26681808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy.
    McCampbell A; Truong D; Broom DC; Allchorne A; Gable K; Cutler RG; Mattson MP; Woolf CJ; Frosch MP; Harmon JM; Dunn TM; Brown RH
    Hum Mol Genet; 2005 Nov; 14(22):3507-21. PubMed ID: 16210380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical feature difference between juvenile amyotrophic lateral sclerosis with SPTLC1 and FUS mutations.
    Wang P; Wei Q; Li H; Wu ZY
    Chin Med J (Engl); 2023 Jan; 136(2):176-183. PubMed ID: 36801857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous
    Guissart C; De la Cruz E; Flabeau O; Grapperon AM; Corazza G; Junilhon L; Delmas JC; Millecamps S; Polge A; Amador MDM; Salachas F; Rochat J; Goizet C; Juntas Morales R; Lumbroso S; Philibert P; Cheillan D; Mouzat K
    J Neurol Neurosurg Psychiatry; 2024 Feb; 95(3):288-290. PubMed ID: 38041669
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional and Molecular Characterization of New
    Rochat J; Blavier A; Ruet S; Vasseur S; Puma A; Desnous B; Chan V; Delmont E; Attarian S; Juntas Morales R; Quadrio I; Vidoni L; Bonello-Palot N; Cheillan D
    Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset severe hereditary sensory and autonomic neuropathy type 1 with S331F SPTLC1 mutation.
    Suh BC; Hong YB; Nakhro K; Nam SH; Chung KW; Choi BO
    Mol Med Rep; 2014 Feb; 9(2):481-6. PubMed ID: 24247255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of serine palmitoyltransferase long chain-1 (SPTLC1) on tyrosine 164 inhibits its activity and promotes cell survival.
    Taouji S; Higa A; Delom F; Palcy S; Mahon FX; Pasquet JM; Bossé R; Ségui B; Chevet E
    J Biol Chem; 2013 Jun; 288(24):17190-201. PubMed ID: 23629659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusion of serine palmitoyltransferase long chain base subunit 2 (SPTLC2) as a common cause for hereditary sensory neuropathy.
    Dawkins JL; Brahmbhatt S; Auer-Grumbach M; Wagner K; Hartung HP; Verhoeven K; Timmerman V; De Jonghe P; Kennerson M; LeGuern E; Nicholson GA
    Neuromuscul Disord; 2002 Oct; 12(7-8):656-8. PubMed ID: 12207934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1.
    Eichler FS; Hornemann T; McCampbell A; Kuljis D; Penno A; Vardeh D; Tamrazian E; Garofalo K; Lee HJ; Kini L; Selig M; Frosch M; Gable K; von Eckardstein A; Woolf CJ; Guan G; Harmon JM; Dunn TM; Brown RH
    J Neurosci; 2009 Nov; 29(46):14646-51. PubMed ID: 19923297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.